Browse the detailed record of transactions filed by BROWN MICHAEL S, Director. Director active across 1 companies, notably Regeneron Pharmaceuticals, INC.. Aggregated, 12 filings have been logged. Total volume traded: €2m. The latest transaction was disclosed on 29 March 2022 — Levée d'options. Regulator: SEC (Form 4). All data is free.
Michael S. Brown is a Board Member at REGENERON PHARMACEUTICALS, INC. He brings expertise in biotechnology and strategy to the board. His role involves overseeing the company's activities and ensuring that it meets its commitments to shareholders.